The purpose of this study was to determine if pharmacologic activation of AMPK by administration of AICAR improves peripheral insulin resistance in preterm baboons by upregulating skeletal muscle SLC2A4 gene expression and GLUT4 protein content or upregulation of other key insulin signaling molecules. The gene discussed is SLC2A4; the disease is Insulin resistance.